CN111671877A - 一种治疗甲胎蛋白升高的中药组合物及其制备方法 - Google Patents
一种治疗甲胎蛋白升高的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN111671877A CN111671877A CN202010569370.2A CN202010569370A CN111671877A CN 111671877 A CN111671877 A CN 111671877A CN 202010569370 A CN202010569370 A CN 202010569370A CN 111671877 A CN111671877 A CN 111671877A
- Authority
- CN
- China
- Prior art keywords
- parts
- fetoprotein
- chinese medicine
- traditional chinese
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种治疗甲胎蛋白升高的中药组合物及其制备方法,涉及中药组合物加工技术领域。所述治疗甲胎蛋白升高的中药组合物由以下原料制成:重楼、白花蛇舌草、半枝莲、板蓝根、莪术、甘草、鸡内金、贯众、薏苡仁、土茯苓、太子参、水红花籽、黄芪、楮实子、郁金、三七粉、半边莲、苏梗。本发明克服了现有技术的不足,具有软坚散结,祛瘀固本的功效,能够直接针对性的用于治疗各类肝炎、肝硬化所致的甲胎蛋白升高进行缓解和降低,且治疗效果好,周期短,无副作用。
Description
技术领域
本发明涉及中药组合物加工技术领域,具体涉及一种治疗甲胎蛋白升高的中药组合物及其制备方法。
背景技术
甲胎蛋白(AFP)是一种糖蛋白,主要由胎儿肝细胞及卵黄囊合成。甲胎蛋白在胎儿血液循环中具有较高的浓度,出生后则下降,至生后2~3月甲胎蛋白基本被白蛋白替代,血液中较难检出,故在成人血清中含量极低。甲胎蛋白与肝癌及多种肿瘤的发生发展密切相关,在多种肿瘤中均可表现出较高浓度,可作为多种肿瘤的阳性检测指标。
正常的成人甲胎蛋白偏高可能提示肝癌,甲胎蛋白是诊断肝癌的一项重要指标,肝癌在出现明显症状之前很早就会有甲胎蛋白偏高的情况,一旦检测出这种情况,必须尽快就医,以确诊疾病,但是甲胎蛋白检测异常并非都是肝癌,还是需要进一步的检查才能确诊。其中肝炎、肝硬化患者也会造成甲胎蛋白检测异常,同时此类症状在治疗时是根据病因治疗,在根治病因的基础上间接降低甲胎蛋白,同时需要长期服用西药,副作用较大,且对甲胎蛋白的影响效果也有一定的欠缺。
发明内容
针对现有技术不足,本发明提供一种治疗甲胎蛋白升高的中药组合物及其制备方法,主要采用中药组合物来治疗由于肝炎、肝硬化带来的甲胎蛋白升高,具有疗效好、治疗周期短且治疗无副作用等优点。
为实现以上目的,本发明的技术方案通过以下技术方案予以实现:
一种治疗甲胎蛋白升高的中药组合物,所述治疗甲胎蛋白升高的中药组合物由以下重量份的原料制成:重楼8-16份、白花蛇舌草12-25份、半枝莲15-30份、板蓝根18-30份、莪术6-9份、甘草6-12份、鸡内金10-18份、贯众10-20份、薏苡仁25-40份、土茯苓15-25份、太子参15-30份、水红花籽15-25份、黄芪15-40份、楮实子15-30份、郁金15-25份、三七粉3-9份、半边莲12-25份、苏梗9-15份。
优选的,所述治疗甲胎蛋白升高的中药组合物由以下重量份的原料制成:重楼12份、白花蛇舌草19份、半枝莲23份、板蓝根24份、莪术7份、甘草9份、鸡内金14份、贯众15份、薏苡仁32份、土茯苓20份、太子参23份、水红花籽20份、黄芪30份、楮实子23份、郁金20份、三七粉6份、半边莲19份、苏梗12份。
优选的,所述中药组用于治疗各类肝炎、肝硬化所致的甲胎蛋白升高。
治疗甲胎蛋白升高的中药组合物的制备方法为:将所有原料混合放入砂锅,加水淹没,武火煎开,文火再煎20min,后过滤,将滤渣继续加水同上述步骤二次煎煮,再过滤,合并两次滤液,得药剂。
本发明提供一种治疗甲胎蛋白升高的中药组合物及其制备方法,与现有技术相比优点在于:
本分明采用多种中药成分混合煎煮,具有软坚散结,祛瘀固本的功效,能够直接针对性的用于治疗各类肝炎、肝硬化所致的甲胎蛋白升高进行缓解和降低,且治疗效果好,周期短,无副作用。
具体实施方式
为使本发明实施例的目的、技术方案和优点更加清楚,下面结合本发明实施例对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例1:
一种治疗甲胎蛋白升高的中药组合物,所述治疗甲胎蛋白升高的中药组合物由以下重量份的原料制成:重楼8份、白花蛇舌草12份、半枝莲15份、板蓝根18份、莪术6份、甘草6份、鸡内金10份、贯众10份、薏苡仁25份、土茯苓15份、太子参15份、水红花籽15份、黄芪15份、楮实子15份、郁金15份、三七粉3份、半边莲12份、苏梗9份。
治疗甲胎蛋白升高的中药组合物的制备方法为:将所有原料混合放入砂锅,加水淹没,武火煎开,文火再煎20min,后过滤,将滤渣继续加水同上述步骤二次煎煮,再过滤,合并两次滤液,得药剂。
实施例2:
一种治疗甲胎蛋白升高的中药组合物,所述治疗甲胎蛋白升高的中药组合物由以下重量份的原料制成:重楼16份、白花蛇舌草25份、半枝莲30份、板蓝根30份、莪术9份、甘草12份、鸡内金18份、贯众20份、薏苡仁40份、土茯苓25份、太子参30份、水红花籽25份、黄芪40份、楮实子30份、郁金25份、三七粉9份、半边莲25份、苏梗15份。
治疗甲胎蛋白升高的中药组合物的制备方法为:将所有原料混合放入砂锅,加水淹没,武火煎开,文火再煎20min,后过滤,将滤渣继续加水同上述步骤二次煎煮,再过滤,合并两次滤液,得药剂。
实施例3:
一种治疗甲胎蛋白升高的中药组合物,所述治疗甲胎蛋白升高的中药组合物由以下重量份的原料制成:重楼12份、白花蛇舌草19份、半枝莲23份、板蓝根24份、莪术7份、甘草9份、鸡内金14份、贯众15份、薏苡仁32份、土茯苓20份、太子参23份、水红花籽20份、黄芪30份、楮实子23份、郁金20份、三七粉6份、半边莲19份、苏梗12份。
治疗甲胎蛋白升高的中药组合物的制备方法为:将所有原料混合放入砂锅,加水淹没,武火煎开,文火再煎20min,后过滤,将滤渣继续加水同上述步骤二次煎煮,再过滤,合并两次滤液,得药剂。
实施例4:
收集自2009年至2017年间我院(怀宁县华春医院)收治的AFP(正常值0—10ug/L)升高患者672例其中AFP均值131ug/L,所有患者治疗期间均已排除肝癌,正常后随访至少3年患者中出现肝癌5例。所有患者双随机分组,对照组只针对病因治疗,治疗组加用上述实施例3所制备药剂,且每日一剂,检测治疗组和对照组治疗前AFP的平均含量,以及治疗2周、4周、8周时的AFP含量,结果如下表所示:
同时在使用实施例3药剂的过程中,患者肝炎或者肝硬化患者的疗程有明显缩短,尤其在用药的2周以后患者的恢复速度有明显加快的趋势。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。在没有更多限制的情况下,由语句“包括一个……”限定的要素,并不排除在包括所述要素的过程、方法、物品或者设备中还存在另外的相同要素。
以上实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的精神和范围。
Claims (4)
1.一种治疗甲胎蛋白升高的中药组合物,其特征在于,所述治疗甲胎蛋白升高的中药组合物由以下重量份的原料制成:重楼8-16份、白花蛇舌草12-25份、半枝莲15-30份、板蓝根18-30份、莪术6-9份、甘草6-12份、鸡内金10-18份、贯众10-20份、薏苡仁25-40份、土茯苓15-25份、太子参15-30份、水红花籽15-25份、黄芪15-40份、楮实子15-30份、郁金15-25份、三七粉3-9份、半边莲12-25份、苏梗9-15份。
2.根据权利要求1所述的一种治疗甲胎蛋白升高的中药组合物,其特征在于,所述治疗甲胎蛋白升高的中药组合物由以下重量份的原料制成:重楼12份、白花蛇舌草19份、半枝莲23份、板蓝根24份、莪术7份、甘草9份、鸡内金14份、贯众15份、薏苡仁32份、土茯苓20份、太子参23份、水红花籽20份、黄芪30份、楮实子23份、郁金20份、三七粉6份、半边莲19份、苏梗12份。
3.根据权利要求1所述的一种治疗甲胎蛋白升高的中药组合物,其特征在于:所述中药组用于治疗各类肝炎、肝硬化所致的甲胎蛋白升高。
4.一种治疗甲胎蛋白升高的中药组合物的制备方法,其特征在于,所述治疗甲胎蛋白升高的中药组合物的制备方法为:将所有原料混合放入砂锅,加水淹没,武火煎开,文火再煎20min,后过滤,将滤渣继续加水同上述步骤二次煎煮,再过滤,合并两次滤液,得药剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010569370.2A CN111671877A (zh) | 2020-06-20 | 2020-06-20 | 一种治疗甲胎蛋白升高的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010569370.2A CN111671877A (zh) | 2020-06-20 | 2020-06-20 | 一种治疗甲胎蛋白升高的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111671877A true CN111671877A (zh) | 2020-09-18 |
Family
ID=72455992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010569370.2A Pending CN111671877A (zh) | 2020-06-20 | 2020-06-20 | 一种治疗甲胎蛋白升高的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111671877A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020076446A1 (en) * | 2000-10-18 | 2002-06-20 | Tzu-Sheng Wu | Novel medicinal herbal composition for treating liver diseases and HIV |
CN1559532A (zh) * | 2004-02-23 | 2005-01-05 | 高和平 | 一种治疗病毒性肝炎的中药组合物 |
-
2020
- 2020-06-20 CN CN202010569370.2A patent/CN111671877A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020076446A1 (en) * | 2000-10-18 | 2002-06-20 | Tzu-Sheng Wu | Novel medicinal herbal composition for treating liver diseases and HIV |
CN1559532A (zh) * | 2004-02-23 | 2005-01-05 | 高和平 | 一种治疗病毒性肝炎的中药组合物 |
Non-Patent Citations (2)
Title |
---|
刘士敬等: "《乙型肝炎防治》", 31 January 2002, 金盾出版社 * |
陈锡林: "败毒活血汤治疗慢性乙型肝炎甲胎蛋白阳性患者42例", 《肝脏》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6696094B2 (en) | Herbal pharmaceutical composition for treatment of HIV/AIDS patients | |
CN104984297A (zh) | 一种药物组合物在制备治疗闭经药物中的用途 | |
CN109908194A (zh) | 一种用于治疗急慢性咽炎的药物及其制备方法 | |
CN101020027B (zh) | 预防和治疗艾滋病的药物组合物及其制备方法和用途 | |
CN111671877A (zh) | 一种治疗甲胎蛋白升高的中药组合物及其制备方法 | |
CN115634275A (zh) | 一种治疗肝癌肝郁脾虚瘀毒证的中药制剂 | |
CN107456497B (zh) | 一种治疗月经不调的药物及其制备方法 | |
CN113209223A (zh) | 一种治疗排卵障碍不孕中药组合物及其制备方法 | |
CN105288538A (zh) | 一种药物组合物用于制备治疗闭经药物中的用途 | |
CN105327121A (zh) | 一种治疗女性绝经后骨质疏松症的中药组合物及其制备方法 | |
CN106075361B (zh) | 一种中药组合物及其制备与应用 | |
CN105169338A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
CN1814153A (zh) | 一种预防和治疗乳腺癌的药物组合物及其制备方法 | |
CN112386671B (zh) | 一种治疗间质性肺疾病的中药组合物及其应用 | |
CN115969936A (zh) | 岭南毒性中药治疗恶性血液病的制备方法 | |
CN112138105B (zh) | 一种治疗支气管扩张症肺脾气虚、痰湿阻肺证的中药组合物及其应用 | |
CN108567926B (zh) | 一种治疗瘀血阻络型自身免疫性肝炎的中药组合物及其制备方法 | |
TWI498119B (zh) | 中藥組成物水萃取物於製備抑制肺癌細胞生長之藥物上之用途 | |
CN101015594A (zh) | 用于治疗哮喘的组合物及其制备方法 | |
CN114159525A (zh) | 一种适用于妊娠期高血压的活血降压组合物 | |
CN114767814A (zh) | 一种缩短慢性阻塞性肺疾病急性加重期病程的制剂及其制备方法 | |
CN105395836A (zh) | 一种中药组合物在制备治疗风温肺热病药物中的用途 | |
CN104740579A (zh) | 经前安片及其制备工艺 | |
CN115804819A (zh) | 一种治疗新型冠状病毒肺炎的中药组合物及其用途 | |
CN115715791A (zh) | 一种防治新型冠状病毒上呼吸道感染性疾病的中药组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200918 |